Drug Pipeline Quarterly Update: September 2021

Drugs in review, drugs with expiring patents, generic availability and more.

September 30, 2021

These quarterly pipeline wrap-ups include new molecular entity approvals, drugs with approvable status from the FDA, potential blockbuster drugs and the dates of expected FDA approval, names of top selling brand-name drugs with generic availability in the past 12 months and names of top selling brand-name drugs that have patents expiring soon.

September 2021 Quarterly Drug Pipeline Update
September 2021 Quarterly Specialty Drug Pipeline Update

Related research

Drug pipeline updates

October 14, 2021

November 2021 decisions expected from the FDA

At Prime Therapeutics (Prime), we’ve positioned ourselves to best prepare our clients to…

Drug pipeline updates

September 12, 2021

October 2021 decisions expected from the FDA

At Prime Therapeutics (Prime), we’ve positioned ourselves to best prepare our clients to…

Drug pipeline updates

September 10, 2021

BioMarin’s Vosoritide aims to be first treatment for achondroplasia

Drug name: vosoritide Manufacturer: BioMarin Condition: Achondroplasia in children from age 2 until…